SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'RAP'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
1pbk | FKBP25 (Homosapiens) | 7 / 9 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)None | 0.30A | 1bkfA-1pbkA:19.1 | 1bkfA-1pbkA:44.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 9 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.83A | 1bkfA-2vcdA:13.2 | 1bkfA-2vcdA:35.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 9 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.82A | 1bkfA-2vcdA:13.2 | 1bkfA-2vcdA:35.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 9 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.75A | 1bkfA-2vcdA:13.2 | 1bkfA-2vcdA:35.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1C9H_A_RAPA108_1 (FKBP12.6) |
1pbk | FKBP25 (Homosapiens) | 7 / 12 | TYR A 135ASP A 146VAL A 171ILE A 172TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.41A | 1c9hA-1pbkA:18.8 | 1c9hA-1pbkA:42.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FAP_A_RAPA108_1 (FK506-BINDINGPROTEIN) |
1pbk | FKBP25 (Homosapiens) | 8 / 12 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.32A | 1fapA-1pbkA:19.6 | 1fapA-1pbkA:43.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FAP_A_RAPA108_1 (FK506-BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.78A | 1fapA-2vcdA:13.7 | 1fapA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FAP_A_RAPA108_1 (FK506-BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.75A | 1fapA-2vcdA:13.7 | 1fapA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FAP_A_RAPA108_1 (FK506-BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.64A | 1fapA-2vcdA:13.7 | 1fapA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKB_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
1pbk | FKBP25 (Homosapiens) | 7 / 12 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)None | 0.29A | 1fkbA-1pbkA:19.6 | 1fkbA-1pbkA:43.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKB_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.87A | 1fkbA-2vcdA:13.6 | 1fkbA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKB_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.84A | 1fkbA-2vcdA:13.6 | 1fkbA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKB_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.70A | 1fkbA-2vcdA:13.6 | 1fkbA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.37A | 1fkfA-1pbkA:19.3 | 1fkfA-1pbkA:43.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.75A | 1fkfA-2vcdA:13.3 | 1fkfA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.72A | 1fkfA-2vcdA:13.3 | 1fkfA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKF_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.62A | 1fkfA-2vcdA:13.3 | 1fkfA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKJ_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
1pbk | FKBP25 (Homosapiens) | 6 / 11 | PHE A 164ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | NoneRAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 1.40A | 1fkjA-1pbkA:19.3 | 1fkjA-1pbkA:43.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKJ_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.38A | 1fkjA-1pbkA:19.3 | 1fkjA-1pbkA:43.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKJ_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.73A | 1fkjA-2vcdA:13.2 | 1fkjA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKJ_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.71A | 1fkjA-2vcdA:13.2 | 1fkjA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKJ_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.61A | 1fkjA-2vcdA:13.2 | 1fkjA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKL_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
1pbk | FKBP25 (Homosapiens) | 8 / 12 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.31A | 1fklA-1pbkA:19.6 | 1fklA-1pbkA:44.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKL_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.86A | 1fklA-2vcdA:13.6 | 1fklA-2vcdA:35.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKL_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.84A | 1fklA-2vcdA:13.6 | 1fklA-2vcdA:35.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FKL_A_RAPA108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.72A | 1fklA-2vcdA:13.6 | 1fklA-2vcdA:35.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PBK_A_RAPA225_1 (FKBP25) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 12 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.80A | 1pbkA-2vcdA:13.4 | 1pbkA-2vcdA:31.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PBK_A_RAPA225_1 (FKBP25) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.63A | 1pbkA-2vcdA:13.4 | 1pbkA-2vcdA:31.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q6I_A_FK5A301_1 (FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA) |
1pbk | FKBP25 (Homosapiens) | 9 / 9 | TYR A 135ASP A 146LEU A 162VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-4.8A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.60A | 1q6iA-1pbkA:15.7 | 1q6iA-1pbkA:25.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Q6I_A_FK5A301_1 (FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 9 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.90A | 1q6iA-2vcdA:19.7 | 1q6iA-2vcdA:37.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Q6I_A_FK5A301_1 (FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 9 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.91A | 1q6iA-2vcdA:19.7 | 1q6iA-2vcdA:37.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Q6I_B_FK5B401_1 (FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.36A | 1q6iB-1pbkA:15.4 | 1q6iB-1pbkA:25.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Q6I_B_FK5B401_1 (FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.88A | 1q6iB-2vcdA:19.5 | 1q6iB-2vcdA:37.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1Q6I_B_FK5B401_1 (FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.84A | 1q6iB-2vcdA:19.5 | 1q6iB-2vcdA:37.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TCO_C_FK5C509_2 (FK506-BINDINGPROTEIN) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.33A | 1tcoC-1pbkA:18.9 | 1tcoC-1pbkA:43.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TCO_C_FK5C509_2 (FK506-BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.86A | 1tcoC-2vcdA:13.3 | 1tcoC-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TCO_C_FK5C509_2 (FK506-BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.77A | 1tcoC-2vcdA:13.3 | 1tcoC-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TCO_C_FK5C509_2 (FK506-BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.67A | 1tcoC-2vcdA:13.3 | 1tcoC-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TCO_C_FK5C509_2 (FK506-BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | VAL A 82ILE A 83TRP A 86TYR A 109PHE A 126 | RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)RAP A 138 ( 4.7A) | 0.99A | 1tcoC-2vcdA:13.3 | 1tcoC-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YAT_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.29A | 1yatA-1pbkA:19.4 | 1yatA-1pbkA:40.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YAT_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.76A | 1yatA-2vcdA:15.0 | 1yatA-2vcdA:31.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YAT_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.83A | 1yatA-2vcdA:15.0 | 1yatA-2vcdA:31.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DG3_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
1pbk | FKBP25 (Homosapiens) | 7 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)None | 0.32A | 2dg3A-1pbkA:19.4 | 2dg3A-1pbkA:43.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DG3_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86ILE A 118PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)NoneRAP A 138 ( 4.7A) | 1.40A | 2dg3A-2vcdA:13.6 | 2dg3A-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DG3_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.83A | 2dg3A-2vcdA:13.6 | 2dg3A-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DG3_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.73A | 2dg3A-2vcdA:13.6 | 2dg3A-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DG4_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
1pbk | FKBP25 (Homosapiens) | 6 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-4.6A)None | 0.33A | 2dg4A-1pbkA:18.8 | 2dg4A-1pbkA:42.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2DG9_A_RAPA501_1 (FK506-BINDINGPROTEIN 1A) |
1pbk | FKBP25 (Homosapiens) | 6 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-4.6A)None | 0.35A | 2dg9A-1pbkA:19.1 | 2dg9A-1pbkA:42.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2FKE_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.36A | 2fkeA-1pbkA:19.3 | 2fkeA-1pbkA:43.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2FKE_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.75A | 2fkeA-2vcdA:13.4 | 2fkeA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2FKE_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.75A | 2fkeA-2vcdA:13.4 | 2fkeA-2vcdA:34.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2FKE_A_FK5A108_1 (FK506 BINDINGPROTEIN) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.64A | 2fkeA-2vcdA:13.4 | 2fkeA-2vcdA:34.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HS2_B_017B203_1 (PROTEASE) |
1pbk | FKBP25 (Homosapiens) | 4 / 6 | TRP A 196LEU A 179ARG A 173GLY A 169 | NoneNoneNoneRAP A 225 (-3.8A) | 1.21A | 2hs2B-1pbkA:undetectable | 2hs2B-1pbkA:21.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VCD_A_RAPA138_1 (OUTER MEMBRANEPROTEIN MIP) |
1pbk | FKBP25 (Homosapiens) | 6 / 11 | TYR A 135PHE A 145ASP A 146VAL A 171ILE A 172TRP A 175 | RAP A 225 (-3.9A)RAP A 225 (-4.6A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A) | 0.75A | 2vcdA-1pbkA:13.4 | 2vcdA-1pbkA:31.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VCD_A_RAPA138_1 (OUTER MEMBRANEPROTEIN MIP) |
1pbk | FKBP25 (Homosapiens) | 6 / 11 | TYR A 135PHE A 145VAL A 171ILE A 172TRP A 175TYR A 198 | RAP A 225 (-3.9A)RAP A 225 (-4.6A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A) | 0.94A | 2vcdA-1pbkA:13.4 | 2vcdA-1pbkA:31.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VN1_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135PHE A 145ASP A 146VAL A 171TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-4.6A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.36A | 2vn1A-1pbkA:18.1 | 2vn1A-1pbkA:35.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VN1_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | PHE A 65ASP A 66VAL A 82TRP A 86PHE A 126 | RAP A 138 (-3.5A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.57A | 2vn1A-2vcdA:14.6 | 2vn1A-2vcdA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VN1_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55PHE A 65ASP A 66VAL A 82TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-3.5A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-2.3A) | 0.63A | 2vn1A-2vcdA:14.6 | 2vn1A-2vcdA:30.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VN1_B_FK5B501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 7 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)None | 0.28A | 2vn1B-1pbkA:18.1 | 2vn1B-1pbkA:35.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VN1_B_FK5B501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.79A | 2vn1B-2vcdA:14.5 | 2vn1B-2vcdA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VN1_B_FK5B501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.73A | 2vn1B-2vcdA:14.5 | 2vn1B-2vcdA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VN1_B_FK5B501_1 (70 KDAPEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.71A | 2vn1B-2vcdA:14.5 | 2vn1B-2vcdA:30.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IHZ_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.42A | 3ihzA-1pbkA:18.1 | 3ihzA-1pbkA:33.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IHZ_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.75A | 3ihzA-2vcdA:14.7 | 3ihzA-2vcdA:32.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IHZ_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.72A | 3ihzA-2vcdA:14.7 | 3ihzA-2vcdA:32.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IHZ_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.56A | 3ihzA-2vcdA:14.7 | 3ihzA-2vcdA:32.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IHZ_A_FK5A501_1 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | VAL A 82ILE A 83TRP A 86TYR A 109PHE A 126 | RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)RAP A 138 ( 4.7A) | 0.89A | 3ihzA-2vcdA:14.7 | 3ihzA-2vcdA:32.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IHZ_A_FK5A501_2 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
1pbk | FKBP25 (Homosapiens) | 4 / 8 | TYR A 135TRP A 175TYR A 198ILE A 208 | RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A) | 0.49A | 3ihzB-1pbkA:18.2 | 3ihzB-1pbkA:33.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IHZ_A_FK5A501_2 (70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 4 / 8 | TYR A 55TRP A 86TYR A 109GLY A 116 | RAP A 138 (-2.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)None | 0.68A | 3ihzB-2vcdA:14.9 | 3ihzB-2vcdA:32.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KZ7_A_RAPA225_1 (FK506-BINDINGPROTEIN 3) |
1pbk | FKBP25 (Homosapiens) | 10 / 10 | TYR A 135ASP A 146LEU A 162LYS A 170VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-4.8A)RAP A 225 (-2.9A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.41A | 3kz7A-1pbkA:22.7 | 3kz7A-1pbkA:95.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KZ7_A_RAPA225_1 (FK506-BINDINGPROTEIN 3) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.77A | 3kz7A-2vcdA:13.6 | 3kz7A-2vcdA:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KZ7_A_RAPA225_1 (FK506-BINDINGPROTEIN 3) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.68A | 3kz7A-2vcdA:13.6 | 3kz7A-2vcdA:35.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.30A | 3o5rA-1pbkA:18.3 | 3o5rA-1pbkA:37.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TYR A 198LYS A 207ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-4.6A)NoneRAP A 225 ( 4.9A)None | 0.54A | 3o5rA-1pbkA:18.3 | 3o5rA-1pbkA:37.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.77A | 3o5rA-2vcdA:14.8 | 3o5rA-2vcdA:28.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.78A | 3o5rA-2vcdA:14.8 | 3o5rA-2vcdA:28.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O5R_A_FK5A1001_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.59A | 3o5rA-2vcdA:14.8 | 3o5rA-2vcdA:28.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RV5_A_DXCA91_0 (TROPONIN C, SLOWSKELETAL AND CARDIACMUSCLES) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 3 / 3 | PHE A 126GLN A 33PHE A 65 | RAP A 138 ( 4.7A)NoneRAP A 138 (-3.5A) | 0.82A | 3rv5A-2vcdA:undetectable | 3rv5A-2vcdA:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UF8_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.24A | 3uf8A-1pbkA:18.1 | 3uf8A-1pbkA:26.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UF8_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.76A | 3uf8A-2vcdA:15.3 | 3uf8A-2vcdA:26.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UF8_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.72A | 3uf8A-2vcdA:15.3 | 3uf8A-2vcdA:26.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UF8_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.64A | 3uf8A-2vcdA:15.3 | 3uf8A-2vcdA:26.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UQA_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.31A | 3uqaA-1pbkA:18.0 | 3uqaA-1pbkA:26.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UQA_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.77A | 3uqaA-2vcdA:15.2 | 3uqaA-2vcdA:27.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UQA_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.74A | 3uqaA-2vcdA:15.2 | 3uqaA-2vcdA:27.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UQA_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.64A | 3uqaA-2vcdA:15.2 | 3uqaA-2vcdA:27.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UQB_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 7 / 8 | TYR A 135VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.26A | 3uqbA-1pbkA:17.9 | 3uqbA-1pbkA:26.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UQB_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 8 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.64A | 3uqbA-2vcdA:15.1 | 3uqbA-2vcdA:26.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UQB_A_FK5A114_1 (UBIQUITIN-LIKEPROTEIN SMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 4 / 8 | VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.84A | 3uqbA-2vcdA:15.1 | 3uqbA-2vcdA:26.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VAW_A_FK5A114_1 (UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.32A | 3vawA-1pbkA:17.4 | 3vawA-1pbkA:26.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VAW_A_FK5A114_1 (UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.76A | 3vawA-2vcdA:15.0 | 3vawA-2vcdA:26.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VAW_A_FK5A114_1 (UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.74A | 3vawA-2vcdA:15.0 | 3vawA-2vcdA:26.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VAW_A_FK5A114_1 (UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.62A | 3vawA-2vcdA:15.0 | 3vawA-2vcdA:26.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRH_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
1pbk | FKBP25 (Homosapiens) | 8 / 12 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.39A | 4drhA-1pbkA:17.3 | 4drhA-1pbkA:38.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DRH_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.81A | 4drhA-2vcdA:14.8 | 4drhA-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DRH_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.81A | 4drhA-2vcdA:14.8 | 4drhA-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DRH_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.72A | 4drhA-2vcdA:14.8 | 4drhA-2vcdA:27.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRH_D_RAPD201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
1pbk | FKBP25 (Homosapiens) | 8 / 12 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.38A | 4drhD-1pbkA:17.3 | 4drhD-1pbkA:38.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DRH_D_RAPD201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.82A | 4drhD-2vcdA:15.0 | 4drhD-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DRH_D_RAPD201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.82A | 4drhD-2vcdA:15.0 | 4drhD-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DRH_D_RAPD201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.70A | 4drhD-2vcdA:15.0 | 4drhD-2vcdA:27.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRI_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.33A | 4driA-1pbkA:18.8 | 4driA-1pbkA:38.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DRI_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.79A | 4driA-2vcdA:14.4 | 4driA-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DRI_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.80A | 4driA-2vcdA:14.4 | 4driA-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DRI_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.70A | 4driA-2vcdA:14.4 | 4driA-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DRI_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | VAL A 82ILE A 83TRP A 86TYR A 109PHE A 126 | RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)RAP A 138 ( 4.7A) | 0.95A | 4driA-2vcdA:14.4 | 4driA-2vcdA:27.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRJ_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.26A | 4drjA-1pbkA:19.1 | 4drjA-1pbkA:38.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRJ_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.79A | 4drjA-2vcdA:14.5 | 4drjA-2vcdA:33.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRJ_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.76A | 4drjA-2vcdA:14.5 | 4drjA-2vcdA:33.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DRJ_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.65A | 4drjA-2vcdA:14.5 | 4drjA-2vcdA:33.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 5 / 11 | PHE A 164ILE A 172TRP A 175TYR A 198PHE A 216 | NoneRAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)None | 1.36A | 4dz2A-1pbkA:17.94dz2B-1pbkA:17.9 | 4dz2A-1pbkA:41.324dz2B-1pbkA:41.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.31A | 4dz2A-1pbkA:17.94dz2B-1pbkA:17.9 | 4dz2A-1pbkA:41.324dz2B-1pbkA:41.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.77A | 4dz2A-2vcdA:15.34dz2B-2vcdA:15.4 | 4dz2A-2vcdA:33.334dz2B-2vcdA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.76A | 4dz2A-2vcdA:15.34dz2B-2vcdA:15.4 | 4dz2A-2vcdA:33.334dz2B-2vcdA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.63A | 4dz2A-2vcdA:15.34dz2B-2vcdA:15.4 | 4dz2A-2vcdA:33.334dz2B-2vcdA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_A_FK5A200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | VAL A 82ILE A 83TRP A 86TYR A 109PHE A 126 | RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)RAP A 138 ( 4.7A) | 0.95A | 4dz2A-2vcdA:15.34dz2B-2vcdA:15.4 | 4dz2A-2vcdA:33.334dz2B-2vcdA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 6 / 11 | PHE A 164ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | NoneRAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 1.36A | 4dz2A-1pbkA:17.94dz2B-1pbkA:17.9 | 4dz2A-1pbkA:41.324dz2B-1pbkA:41.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.32A | 4dz2A-1pbkA:17.94dz2B-1pbkA:17.9 | 4dz2A-1pbkA:41.324dz2B-1pbkA:41.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.73A | 4dz2A-2vcdA:15.34dz2B-2vcdA:15.4 | 4dz2A-2vcdA:33.334dz2B-2vcdA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.74A | 4dz2A-2vcdA:15.34dz2B-2vcdA:15.4 | 4dz2A-2vcdA:33.334dz2B-2vcdA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.63A | 4dz2A-2vcdA:15.34dz2B-2vcdA:15.4 | 4dz2A-2vcdA:33.334dz2B-2vcdA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ2_B_FK5B200_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | VAL A 82ILE A 83TRP A 86TYR A 109PHE A 126 | RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)RAP A 138 ( 4.7A) | 0.92A | 4dz2A-2vcdA:15.34dz2B-2vcdA:15.4 | 4dz2A-2vcdA:33.334dz2B-2vcdA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 5 / 10 | PHE A 164ILE A 172TRP A 175TYR A 198PHE A 216 | NoneRAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)None | 1.33A | 4dz3A-1pbkA:18.1 | 4dz3A-1pbkA:41.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.32A | 4dz3A-1pbkA:18.1 | 4dz3A-1pbkA:41.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.74A | 4dz3A-2vcdA:15.2 | 4dz3A-2vcdA:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.73A | 4dz3A-2vcdA:15.2 | 4dz3A-2vcdA:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.59A | 4dz3A-2vcdA:15.2 | 4dz3A-2vcdA:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | VAL A 82ILE A 83TRP A 86TYR A 109PHE A 126 | RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)RAP A 138 ( 4.7A) | 0.91A | 4dz3A-2vcdA:15.2 | 4dz3A-2vcdA:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 6 / 10 | PHE A 164ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | NoneRAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 1.33A | 4dz3B-1pbkA:18.1 | 4dz3B-1pbkA:41.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.31A | 4dz3B-1pbkA:18.1 | 4dz3B-1pbkA:41.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.76A | 4dz3B-2vcdA:15.2 | 4dz3B-2vcdA:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.72A | 4dz3B-2vcdA:15.2 | 4dz3B-2vcdA:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.61A | 4dz3B-2vcdA:15.2 | 4dz3B-2vcdA:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DZ3_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | VAL A 82ILE A 83TRP A 86TYR A 109PHE A 126 | RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)RAP A 138 ( 4.7A) | 0.95A | 4dz3B-2vcdA:15.2 | 4dz3B-2vcdA:34.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LAX_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
1pbk | FKBP25 (Homosapiens) | 6 / 10 | PHE A 164ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | NoneRAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 1.47A | 4laxA-1pbkA:19.1 | 4laxA-1pbkA:33.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LAX_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175LYS A 207ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)NoneRAP A 225 ( 4.9A)None | 0.71A | 4laxA-1pbkA:19.1 | 4laxA-1pbkA:33.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4LAX_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.28A | 4laxA-1pbkA:19.1 | 4laxA-1pbkA:33.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LAX_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.74A | 4laxA-2vcdA:14.2 | 4laxA-2vcdA:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LAX_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.74A | 4laxA-2vcdA:14.2 | 4laxA-2vcdA:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LAX_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.61A | 4laxA-2vcdA:14.2 | 4laxA-2vcdA:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LAX_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | VAL A 82ILE A 83TRP A 86TYR A 109PHE A 126 | RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)RAP A 138 ( 4.7A) | 0.90A | 4laxA-2vcdA:14.2 | 4laxA-2vcdA:22.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NNR_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
1pbk | FKBP25 (Homosapiens) | 8 / 12 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.27A | 4nnrA-1pbkA:15.64nnrB-1pbkA:15.6 | 4nnrA-1pbkA:38.624nnrB-1pbkA:38.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NNR_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.74A | 4nnrA-2vcdA:10.64nnrB-2vcdA:10.7 | 4nnrA-2vcdA:30.004nnrB-2vcdA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NNR_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.75A | 4nnrA-2vcdA:10.64nnrB-2vcdA:10.7 | 4nnrA-2vcdA:30.004nnrB-2vcdA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NNR_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.62A | 4nnrA-2vcdA:10.64nnrB-2vcdA:10.7 | 4nnrA-2vcdA:30.004nnrB-2vcdA:30.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NNR_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.26A | 4nnrB-1pbkA:15.6 | 4nnrB-1pbkA:38.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NNR_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.76A | 4nnrB-2vcdA:10.7 | 4nnrB-2vcdA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NNR_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.76A | 4nnrB-2vcdA:10.7 | 4nnrB-2vcdA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NNR_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.62A | 4nnrB-2vcdA:10.7 | 4nnrB-2vcdA:30.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ODO_A_FK5A205_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD) |
1pbk | FKBP25 (Homosapiens) | 6 / 10 | TYR A 135ASP A 146LEU A 162ILE A 172TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-4.8A)RAP A 225 (-3.9A)RAP A 225 (-4.6A)None | 0.54A | 4odoA-1pbkA:11.6 | 4odoA-1pbkA:27.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ODO_B_FK5B203_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD) |
1pbk | FKBP25 (Homosapiens) | 6 / 10 | TYR A 135ASP A 146LEU A 162ILE A 172TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-4.8A)RAP A 225 (-3.9A)RAP A 225 (-4.6A)None | 0.52A | 4odoB-1pbkA:11.4 | 4odoB-1pbkA:27.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ODO_C_FK5C204_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD) |
1pbk | FKBP25 (Homosapiens) | 6 / 10 | TYR A 135ASP A 146LEU A 162ILE A 172TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-4.8A)RAP A 225 (-3.9A)RAP A 225 (-4.6A)None | 0.51A | 4odoC-1pbkA:11.2 | 4odoC-1pbkA:27.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ODR_A_FK5A201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA) |
1pbk | FKBP25 (Homosapiens) | 7 / 12 | TYR A 135ASP A 146LEU A 162ILE A 172TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-4.8A)RAP A 225 (-3.9A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.49A | 4odrA-1pbkA:13.24odrB-1pbkA:13.2 | 4odrA-1pbkA:28.064odrB-1pbkA:28.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ODR_B_FK5B201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA) |
1pbk | FKBP25 (Homosapiens) | 6 / 11 | TYR A 135ASP A 146LEU A 162ILE A 172TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-4.8A)RAP A 225 (-3.9A)RAP A 225 (-4.6A)None | 0.48A | 4odrA-1pbkA:13.24odrB-1pbkA:13.2 | 4odrA-1pbkA:28.064odrB-1pbkA:28.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QT2_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.31A | 4qt2A-1pbkA:18.5 | 4qt2A-1pbkA:37.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QT2_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.81A | 4qt2A-2vcdA:14.9 | 4qt2A-2vcdA:31.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QT2_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.80A | 4qt2A-2vcdA:14.9 | 4qt2A-2vcdA:31.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QT2_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.68A | 4qt2A-2vcdA:14.9 | 4qt2A-2vcdA:31.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QT3_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.37A | 4qt3A-1pbkA:17.4 | 4qt3A-1pbkA:33.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QT3_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.81A | 4qt3A-2vcdA:14.7 | 4qt3A-2vcdA:30.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QT3_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.79A | 4qt3A-2vcdA:14.7 | 4qt3A-2vcdA:30.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QT3_A_RAPA202_1 (FK506-BINDINGPROTEIN (FKBP)-TYPEPEPTIDYL-PROPYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.72A | 4qt3A-2vcdA:14.7 | 4qt3A-2vcdA:30.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5B8I_C_FK5C201_3 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 12 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.34A | 5b8iC-1pbkA:18.9 | 5b8iC-1pbkA:41.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5B8I_C_FK5C201_3 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.82A | 5b8iC-2vcdA:12.8 | 5b8iC-2vcdA:30.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5B8I_C_FK5C201_3 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.86A | 5b8iC-2vcdA:12.8 | 5b8iC-2vcdA:30.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5B8I_C_FK5C201_3 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.68A | 5b8iC-2vcdA:12.8 | 5b8iC-2vcdA:30.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5D75_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
1pbk | FKBP25 (Homosapiens) | 9 / 11 | LEU A 162VAL A 171ILE A 172TRP A 175TYR A 198GLN A 203ALA A 206ILE A 208PHE A 216 | RAP A 225 (-4.8A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)NoneRAP A 225 ( 3.9A)RAP A 225 ( 4.9A)None | 1.05A | 5d75A-1pbkA:22.0 | 5d75A-1pbkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5D75_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
1pbk | FKBP25 (Homosapiens) | 10 / 11 | TYR A 135ASP A 146LEU A 162VAL A 171ILE A 172TRP A 175TYR A 198ALA A 206ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-4.8A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 3.9A)RAP A 225 ( 4.9A)None | 0.75A | 5d75A-1pbkA:22.0 | 5d75A-1pbkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5D75_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.72A | 5d75A-2vcdA:13.7 | 5d75A-2vcdA:30.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5D75_A_FK5A301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.82A | 5d75A-2vcdA:13.7 | 5d75A-2vcdA:30.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GPG_A_RAPA301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
1pbk | FKBP25 (Homosapiens) | 10 / 11 | TYR A 135ASP A 146LEU A 162LYS A 170VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-4.8A)RAP A 225 (-2.9A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.54A | 5gpgA-1pbkA:21.9 | 5gpgA-1pbkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GPG_A_RAPA301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
1pbk | FKBP25 (Homosapiens) | 10 / 11 | TYR A 135ASP A 146LEU A 162VAL A 171ILE A 172TRP A 175TYR A 198ALA A 206ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-4.8A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 3.9A)RAP A 225 ( 4.9A)None | 0.56A | 5gpgA-1pbkA:21.9 | 5gpgA-1pbkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GPG_A_RAPA301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.84A | 5gpgA-2vcdA:14.0 | 5gpgA-2vcdA:33.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5GPG_A_RAPA301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.64A | 5gpgA-2vcdA:14.0 | 5gpgA-2vcdA:33.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HKG_A_RAPA201_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B) |
1pbk | FKBP25 (Homosapiens) | 7 / 12 | TYR A 135ASP A 146VAL A 171ILE A 172TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.38A | 5hkgA-1pbkA:19.1 | 5hkgA-1pbkA:42.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HUA_A_FK5A201_1 (FK506-BINDINGPROTEIN 1) |
1pbk | FKBP25 (Homosapiens) | 7 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)None | 0.25A | 5huaA-1pbkA:19.6 | 5huaA-1pbkA:42.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HUA_A_FK5A201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.73A | 5huaA-2vcdA:15.0 | 5huaA-2vcdA:34.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HUA_A_FK5A201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.84A | 5huaA-2vcdA:15.0 | 5huaA-2vcdA:34.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_A_FK5A201_1 (FK506-BINDINGPROTEIN 1) |
1pbk | FKBP25 (Homosapiens) | 7 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A) | 0.45A | 5hw8A-1pbkA:17.95hw8D-1pbkA:18.1 | 5hw8A-1pbkA:40.005hw8D-1pbkA:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_A_FK5A201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 11 | TYR A 55ASP A 66ILE A 83TRP A 86TYR A 109ILE A 118 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)None | 1.02A | 5hw8A-2vcdA:13.05hw8D-2vcdA:12.9 | 5hw8A-2vcdA:34.905hw8D-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_A_FK5A201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.91A | 5hw8A-2vcdA:13.05hw8D-2vcdA:12.9 | 5hw8A-2vcdA:34.905hw8D-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_B_FK5B201_1 (FK506-BINDINGPROTEIN 1) |
1pbk | FKBP25 (Homosapiens) | 7 / 11 | TYR A 135ASP A 146VAL A 171TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.40A | 5hw8B-1pbkA:17.9 | 5hw8B-1pbkA:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_B_FK5B201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.92A | 5hw8B-2vcdA:13.2 | 5hw8B-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_C_FK5C201_1 (FK506-BINDINGPROTEIN 1) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198LEU A 214PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)NoneNone | 0.41A | 5hw8C-1pbkA:17.85hw8H-1pbkA:14.8 | 5hw8C-1pbkA:40.005hw8H-1pbkA:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_C_FK5C201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86TYR A 109PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)RAP A 138 ( 4.7A) | 0.99A | 5hw8C-2vcdA:13.05hw8H-2vcdA:11.5 | 5hw8C-2vcdA:34.905hw8H-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_C_FK5C201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 10 | ASP A 66VAL A 82ILE A 83TYR A 109LEU A 124PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-3.8A)NoneRAP A 138 ( 4.7A) | 1.12A | 5hw8C-2vcdA:13.05hw8H-2vcdA:11.5 | 5hw8C-2vcdA:34.905hw8H-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_C_FK5C201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.93A | 5hw8C-2vcdA:13.05hw8H-2vcdA:11.5 | 5hw8C-2vcdA:34.905hw8H-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_D_FK5D201_1 (FK506-BINDINGPROTEIN 1) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.40A | 5hw8D-1pbkA:18.1 | 5hw8D-1pbkA:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_D_FK5D201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.83A | 5hw8D-2vcdA:12.9 | 5hw8D-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_D_FK5D201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.88A | 5hw8D-2vcdA:12.9 | 5hw8D-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_D_FK5D201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.68A | 5hw8D-2vcdA:12.9 | 5hw8D-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_E_FK5E201_1 (FK506-BINDINGPROTEIN 1) |
1pbk | FKBP25 (Homosapiens) | 7 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A) | 1.46A | 5hw8E-1pbkA:18.3 | 5hw8E-1pbkA:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_E_FK5E201_1 (FK506-BINDINGPROTEIN 1) |
1pbk | FKBP25 (Homosapiens) | 7 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)None | 0.42A | 5hw8E-1pbkA:18.3 | 5hw8E-1pbkA:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_E_FK5E201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.91A | 5hw8E-2vcdA:12.9 | 5hw8E-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_E_FK5E201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.87A | 5hw8E-2vcdA:12.9 | 5hw8E-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_E_FK5E201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.69A | 5hw8E-2vcdA:12.9 | 5hw8E-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_F_FK5F201_1 (FK506-BINDINGPROTEIN 1) |
1pbk | FKBP25 (Homosapiens) | 7 / 12 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)None | 0.41A | 5hw8B-1pbkA:17.95hw8F-1pbkA:15.05hw8G-1pbkA:17.4 | 5hw8B-1pbkA:40.005hw8F-1pbkA:40.005hw8G-1pbkA:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_F_FK5F201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 12 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.79A | 5hw8B-2vcdA:13.25hw8F-2vcdA:10.55hw8G-2vcdA:13.1 | 5hw8B-2vcdA:34.905hw8F-2vcdA:34.905hw8G-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_F_FK5F201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 12 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109PHE A 126 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A)RAP A 138 ( 4.7A) | 0.85A | 5hw8B-2vcdA:13.25hw8F-2vcdA:10.55hw8G-2vcdA:13.1 | 5hw8B-2vcdA:34.905hw8F-2vcdA:34.905hw8G-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_G_FK5G201_2 (FK506-BINDINGPROTEIN 1) |
1pbk | FKBP25 (Homosapiens) | 7 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A) | 1.41A | 5hw8G-1pbkA:17.4 | 5hw8G-1pbkA:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_G_FK5G201_2 (FK506-BINDINGPROTEIN 1) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.38A | 5hw8G-1pbkA:17.4 | 5hw8G-1pbkA:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_G_FK5G201_2 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.75A | 5hw8G-2vcdA:13.1 | 5hw8G-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_G_FK5G201_2 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.89A | 5hw8G-2vcdA:13.1 | 5hw8G-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_H_FK5H201_1 (FK506-BINDINGPROTEIN 1) |
1pbk | FKBP25 (Homosapiens) | 6 / 8 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)None | 0.53A | 5hw8H-1pbkA:14.8 | 5hw8H-1pbkA:40.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HW8_H_FK5H201_1 (FK506-BINDINGPROTEIN 1) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 8 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.75A | 5hw8H-2vcdA:11.5 | 5hw8H-2vcdA:34.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HWC_A_FK5A201_1 (FK506-BINDINGPROTEIN 1A) |
1pbk | FKBP25 (Homosapiens) | 8 / 11 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.30A | 5hwcA-1pbkA:19.6 | 5hwcA-1pbkA:43.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HWC_A_FK5A201_1 (FK506-BINDINGPROTEIN 1A) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 11 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.75A | 5hwcA-2vcdA:14.1 | 5hwcA-2vcdA:31.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HWC_A_FK5A201_1 (FK506-BINDINGPROTEIN 1A) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 6 / 11 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.83A | 5hwcA-2vcdA:14.1 | 5hwcA-2vcdA:31.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6MKE_A_FK5A201_0 (PEPTIDYLPROLYLISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 12 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.40A | 6mkeA-1pbkA:18.16mkeD-1pbkA:18.1 | 6mkeA-1pbkA:36.996mkeD-1pbkA:36.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_A_FK5A201_0 (PEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.79A | 6mkeA-2vcdA:14.66mkeD-2vcdA:14.5 | 6mkeA-2vcdA:27.786mkeD-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_A_FK5A201_0 (PEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.75A | 6mkeA-2vcdA:14.66mkeD-2vcdA:14.5 | 6mkeA-2vcdA:27.786mkeD-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_A_FK5A201_0 (PEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.69A | 6mkeA-2vcdA:14.66mkeD-2vcdA:14.5 | 6mkeA-2vcdA:27.786mkeD-2vcdA:27.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6MKE_B_FK5B201_0 (PEPTIDYLPROLYLISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 12 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.40A | 6mkeB-1pbkA:18.16mkeC-1pbkA:18.3 | 6mkeB-1pbkA:36.996mkeC-1pbkA:36.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_B_FK5B201_0 (PEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.80A | 6mkeB-2vcdA:14.56mkeC-2vcdA:14.5 | 6mkeB-2vcdA:27.786mkeC-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_B_FK5B201_0 (PEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.75A | 6mkeB-2vcdA:14.56mkeC-2vcdA:14.5 | 6mkeB-2vcdA:27.786mkeC-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_B_FK5B201_0 (PEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 12 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.66A | 6mkeB-2vcdA:14.56mkeC-2vcdA:14.5 | 6mkeB-2vcdA:27.786mkeC-2vcdA:27.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6MKE_C_FK5C201_1 (PEPTIDYLPROLYLISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.33A | 6mkeC-1pbkA:18.3 | 6mkeC-1pbkA:36.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_C_FK5C201_1 (PEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.82A | 6mkeC-2vcdA:14.5 | 6mkeC-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_C_FK5C201_1 (PEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.75A | 6mkeC-2vcdA:14.5 | 6mkeC-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_C_FK5C201_1 (PEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.66A | 6mkeC-2vcdA:14.5 | 6mkeC-2vcdA:27.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6MKE_D_FK5D201_1 (PEPTIDYLPROLYLISOMERASE) |
1pbk | FKBP25 (Homosapiens) | 8 / 10 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.39A | 6mkeD-1pbkA:18.1 | 6mkeD-1pbkA:36.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_D_FK5D201_1 (PEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.83A | 6mkeD-2vcdA:14.5 | 6mkeD-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_D_FK5D201_1 (PEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.76A | 6mkeD-2vcdA:14.5 | 6mkeD-2vcdA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MKE_D_FK5D201_1 (PEPTIDYLPROLYLISOMERASE) |
2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) | 5 / 10 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.64A | 6mkeD-2vcdA:14.5 | 6mkeD-2vcdA:27.78 |